Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Insel Gruppe AG, University Hospital Bern
With
University of Bern
The severity of coronavirus disease 2019 (COVID-19) ranges from asymptomatic infection to severe illness requiring mechanical ventilation. Immunological factors which lead to severe disease in certain COVID-19 patients remain incompletely understood. Neurological damage and complement activation may be a consequence of excess inflammation in severe COVID-19. The investigators plan to study the innate and adaptive immune response and potentially associated complications such as neurological damage and complement activation in mild, moderate and severe COVID-19 courses.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
PCR confirmed SARS-Cov-2 infection
You may not be if
Refusal to participate
Age \< 18 years
Clareo Health | Characterizing the Immune Response and Neuronal Damage in COVID-19
